Anthera Pharmaceuticals Inc (NASDAQ: ANTH) is having an overwhelmingly strong day in the market, seeing massive gains as traders get excited. The gains started just after the stock got into oversold territory as traders sent the stock skyrocketing to the top. However, is there something to this one that traders are onto? Today, we’ll talk … Read more
Anthera Pharmaceuticals Inc (NASDAQ: ANTH) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company was at the center of news surrounding a new analyst initiation with a massive price target. Today, we’ll talk about the news, what we’re seeing from the stock, and what we’ll be watching … Read more
Anthera Pharmaceuticals Inc (NASDAQ: ANTH) is having a great trading session in the market today, and for good reason. The company announced the results from a key Phase 3 clinical study. Today, we’ll talk about the results, what we’re seeing from the stock, and what we’ll be watching for with regard to ANTH ahead. ANTH Gains … Read more
Anthera Pharmaceuticals Inc (NASDAQ: ANTH) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced top-line data from a key clinical trial, leading to excitement among investors and sending the stock toward the top. Of course, our friends at Trade Ideas were the first to alert … Read more
Anthera Pharmaceuticals (NASDAQ: ANTH) Anthera Pharmaceuticals is having an overwhelmingly rough day in the market today. After announcing a public offering in the after-hours yesterday, the stock went on a steep dive, causing it to open on an exceptionally low note today. Below, we’ll talk about the offering, what we’re seeing from the stock, and … Read more
Anthera Pharma (NASDAQ: ANTH) Anthera Pharma is of to what looks like it will be a horrible day in the market today. While the opening bell hasn’t rung just yet, the stock is already experiencing massive declines in pre-market. Below, we’ll talk about what we’re seeing from the stock, why, and what we’ll be watching … Read more
Anthera Pharma (NASDAQ: ANTH) Anthera Pharma is having an incredibly hard time in the market today, and for good reason. The company announced negative news with regard to a Phase 3 study. Below, we’ll talk about what we’re seeing from the stock, why, and what we can expect to see from ANTH ahead. ANTH Takes … Read more
The biotech market is looking great today; with a good percentage of biotechnology stocks in the green today. After looking through the industry, I’ve found 3 stocks that are not only growing, but seem to be strong growth opportunities for the future. Here they are… Acura Pharmaceuticals Climbs On Agreement With Bayer Acura Pharmaceuticals, Inc. … Read more
While this morning was a bit of a rough start for biotech stocks, it seems as though things are changing rather quickly from red to green. In the space, there are several stocks gaining, but I’ve dug out what are some of the biggest gainers so far today. Here’s the scoop… CIGNA Corporation Climbs On … Read more
If you looked at the biotech space yesterday, you were looking at a sea of red. However, today, things are working out to be much different. There are several biotech stocks out there that are doing very well. With that said, here is a list of my top 5 biotech picks for the day. Watch … Read more